Archives merck

by in
Entry Author Date Location
East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More 07/31/15 Boston
vTv Therapeutics IPO Raises $117M For Alzheimer’s, Diabetes Drugs 07/30/15 Raleigh Durham
Sanofi, Regeneron Set Sights on Immuno-Oncology With New $2B+ Pact 07/28/15 New York
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
With $22M Shot of Venture, Sutro Spinout Aims For Better Vaccines 07/23/15 San Francisco
Scynexis Sells CRO Business to Avista, Turns Focus to Antifungal Drug 07/23/15 Raleigh Durham
Ra Pharma Gets $58.5M in Crossover Cash to Target Rare Blood Disease 07/23/15 Boston
RaNA CEO Renaud Turns To A Former Backer To Lead $55M Series B 07/23/15 Boston
25 Years in Biotech 06/22/15 Boston
Flagship CEO on Backing NY Biotech, Moderna, and Investing in a Boom 06/22/15 New York
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
Lycera’s End Game? $104M Celgene Deal Could Lead to Buyout 06/11/15 Detroit
XTuit Gets $22M From NEA, Polaris to Battle Cancer, Liver Disease 06/11/15 Boston
With $30M, Spero Broadens Fight Against Drug-Resistant Bugs 06/08/15 Boston
ASCO Roundup: Checkpoints, Pushback Against Prices, CAR-T & More 06/02/15 National
The Innovation Challenge: Assessing BioPharma Startups 05/04/15 Seattle
Intarcia, Still Private, Nabs $225M More For Diabetes Device 04/28/15 Boston
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer 04/21/15 Boston
With Fresh $14M, Tal Seeks Answers About Magnetic Depression Relief 04/21/15 Boston
Levin Steps in as Ovid CEO, Confirms Plan to Target Rare Neuro Diseases 04/16/15 New York
Blend Therapeutics Taps Former Clinical Data Chief Fromkin As New CEO 04/13/15 Boston
Academia vs. BioPharma: Young Scientists Between A Rock and A Hard Place 04/06/15 Seattle
East Coast Biotech Roundup: NY Bio Fund, Sarepta, ZappRx, & More 04/03/15 Boston
Bioforward, Wisconsin Biotech Trade Group, Names 2nd CEO in 7 Months 04/01/15 Wisconsin
Pivoting From IPO, Syndax Inks Combo Trial Deal With Merck 03/31/15 Boston
Six Takeaways From “New York’s Life Science Disruptors” 03/16/15 New York
West Coast Biotech Roundup: Flexus, NGM, Illumina, Bob Klein & More 02/26/15 San Francisco
Well-Funded NGM Bio Nabs $200M To Boost Merck’s Metabolic Pipeline 02/23/15 San Francisco
San Antonio’s Evestra Takes $5M Loan for Gynecological Treatments 02/19/15 Texas
Page 1 of 17 next page »